Prevalence and mortality of tuberculosis at HIV diagnosis in Spain, 2004–2024

dc.contributor.authorNavarro Soler, Roser
dc.contributor.authorMuriel, Alfonso
dc.contributor.authorMontejano, Rocío
dc.contributor.authorBernardino, José I.
dc.contributor.authorGutiérrez, Félix
dc.contributor.authorAmo de Palacios, Ana de
dc.contributor.authorFernández Felix, Borja M.
dc.contributor.authorGonzález Sanz, Marta
dc.contributor.authorIzquierdo, Rebeca
dc.contributor.authorFernández Castelao, Santiago
dc.contributor.authorMartínez Sanz, Javier
dc.contributor.authorCastillo Navarro, Antonia Maria
dc.contributor.authorSaumoy, Maria
dc.contributor.authorMoreno, Santiago
dc.contributor.authorSerrano Villar, Sergio
dc.date.accessioned2026-07-01T15:34:57Z
dc.date.available2026-07-01T15:34:57Z
dc.date.issued2026-03-26
dc.date.updated2026-05-29T09:39:41Z
dc.description.abstractBackground: Tuberculosis coinfection at HIV diagnosis drives early morbidity and mortality. We estimated tuberculosis prevalence at HIV diagnosis over two decades in a Spanish cohort and quantified its determinants and outcomes. Methods: We analyzed 19,058 ART-naive adults in CoRIS (2004-2024). Prevalent tuberculosis was defined as a disease diagnosed from the date of HIV diagnosis up to 6 months after ART initiation. Predictors were identified using multivariable logistic regression; mortality was assessed using Kaplan-Meier and competing-risk methods. Results: Prevalence was 2.2% (426/19,058), declining from 4.9% (20 04-20 08) to 0.8% (2019-2024), an 83% reduction ( P < 0.001). Despite this decline, affected individuals presented with increasingly advanced immunosuppression. Strong independent predictors included geographical origin (Sub-Saharan Africa OR = 4.3; Latin America OR = 1.6), positive TB screening (OR = 7.5), viral load > 1,0 0 0,0 0 0 copies/ml (OR = 2.9), injection drug use (OR = 2.9), and age >50 years (OR = 6.7), whereas university education (OR = 0.3) and CD4 >500 cells/pl (OR = 0.5) were protective. Model discrimination was good (AUC = 0.84). Mortality was higher with tuberculosis (15.0% vs 4.1%; RR = 3.6; 5-year survival 87% vs 97%). Conclusions: Although prevalence has declined substantially, tuberculosis at HIV diagnosis remains concentrated in high-risk groups and confers excess mortality. Targeted screening and prompt ART remain essential, particularly for migrants from high-burden regions. (c) 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1201-9712
dc.identifier.pmid41903865
dc.identifier.urihttps://hdl.handle.net/2445/230357
dc.language.isoeng
dc.publisherElsevier
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.ijid.2026.108567
dc.relation.ispartofInternational Journal of Infectious Diseases, 2026, vol. 167, p. 108567
dc.relation.urihttps://doi.org/10.1016/j.ijid.2026.108567
dc.rightscc-by-nc-nd (c) Navarro Soler, Roser et al., 2026
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationTuberculosica
dc.subject.classificationMortalitatca
dc.subject.classificationFactors de risc en les malaltiesca
dc.subject.classificationEspanyaca
dc.subject.otherTuberculosisen
dc.subject.otherMortalityen
dc.subject.otherRisk factors in diseasesen
dc.subject.otherSpainen
dc.titlePrevalence and mortality of tuberculosis at HIV diagnosis in Spain, 2004–2024
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S120197122600202X-main.pdf
Mida:
2.3 MB
Format:
Adobe Portable Document Format